CRDMO Syngene International has appointed Siddharth Mittal as Managing Director and Chief Executive Officer. 

Mittal succeeds Peter Bains, who completed his tenure as Managing Director & CEO on 30 June 2026.  

Mittal joins Syngene from Biocon Limited, where he most recently served as the Managing Director and Chief Executive Officer. 

During his thirteen years at Biocon, Mittal helped shape the strategic direction of the company that positioned it for long term growth, strengthening its commercial operations, expanding its presence across global markets, securing key regulatory approvals and successfully commercialising Biocon’s GLP-1 portfolio across major international markets.  

“I am delighted to welcome Siddharth as the Managing Director and CEO of Syngene,” commented Kiran Mazumdar-Shaw, Executive Chairperson of Syngene International. 

“Having worked closely with Siddharth for many years, I have seen first hand his ability to lead businesses through period of change, build strong teams and deliver transformation and sustainable growth. Having built a strong reputation for scientific excellence, quality and customer trust, Syngene is now at an inflection point in its journey.  

“As the industry evolves and customer expectations continue to rise, I am confident Siddharth’s leadership, commercial acumen and execution focus will help Syngene unlock its full potential and create long-term value for our customers, employees and shareholders.”